Assessing patients' information needs regarding drug-drug interactions

Alex Mutebi, Terri L Warholak, Lisa E. Hines, Rose Plummer, Daniel C Malone

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To assess patients' information needs regarding drug-drug interactions (DDIs) to inform patient DDI education resources. Design: Cross-sectional study. Setting: Online (United States in May 2011). Participants: Registered users of an online medication monitoring service (MediGuard). Intervention: Online questionnaire. Main outcome measure: Participants' information needs regarding DDIs and perceived importance of questions related to detecting and preventing harm from DDIs. Results: Characteristics of the 100 surveyed participants were as follows: 57% women, 88% white, 96% non-Hispanic, 71% retired, mean (±SD) age 65.2 ± 9.7 years (range 35-86). The number of prescription medications ranged from 2 to 22 (median 7) and the number of over-the-counter (OTC) medications from 1 to 10 (4). The most common concerns cited by participants were identification of interacting medications, seriousness of DDIs, interactions with OTC medications, interactions with foods, exacerbating comorbidities, short- and long-term adverse effects, signs and frequency of DDIs, and how to minimize adverse effects. Statistically significant differences based on gender, number of prescriptions, and number of OTC medications were observed in rankings of the importance of some DDI questions (P < 0.05). Conclusion: Patient-centered DDI education programs should consider addressing the seriousness of DDIs, the effect of DDIs on comorbidities, and interactions with OTC medications and foods and determining methods for identifying, minimizing, and managing DDIs.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalJournal of the American Pharmacists Association
Volume53
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Drug interactions
Drug Interactions
Pharmaceutical Preparations
Prescriptions
Comorbidity
Education
Food-Drug Interactions

Keywords

  • Drug information
  • Drug interactions
  • Patient preferences

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Pharmacology (nursing)

Cite this

Assessing patients' information needs regarding drug-drug interactions. / Mutebi, Alex; Warholak, Terri L; Hines, Lisa E.; Plummer, Rose; Malone, Daniel C.

In: Journal of the American Pharmacists Association, Vol. 53, No. 1, 01.2013, p. 39-45.

Research output: Contribution to journalArticle

@article{8657c0f6eaf648128ebfd15f680822ee,
title = "Assessing patients' information needs regarding drug-drug interactions",
abstract = "Objective: To assess patients' information needs regarding drug-drug interactions (DDIs) to inform patient DDI education resources. Design: Cross-sectional study. Setting: Online (United States in May 2011). Participants: Registered users of an online medication monitoring service (MediGuard). Intervention: Online questionnaire. Main outcome measure: Participants' information needs regarding DDIs and perceived importance of questions related to detecting and preventing harm from DDIs. Results: Characteristics of the 100 surveyed participants were as follows: 57{\%} women, 88{\%} white, 96{\%} non-Hispanic, 71{\%} retired, mean (±SD) age 65.2 ± 9.7 years (range 35-86). The number of prescription medications ranged from 2 to 22 (median 7) and the number of over-the-counter (OTC) medications from 1 to 10 (4). The most common concerns cited by participants were identification of interacting medications, seriousness of DDIs, interactions with OTC medications, interactions with foods, exacerbating comorbidities, short- and long-term adverse effects, signs and frequency of DDIs, and how to minimize adverse effects. Statistically significant differences based on gender, number of prescriptions, and number of OTC medications were observed in rankings of the importance of some DDI questions (P < 0.05). Conclusion: Patient-centered DDI education programs should consider addressing the seriousness of DDIs, the effect of DDIs on comorbidities, and interactions with OTC medications and foods and determining methods for identifying, minimizing, and managing DDIs.",
keywords = "Drug information, Drug interactions, Patient preferences",
author = "Alex Mutebi and Warholak, {Terri L} and Hines, {Lisa E.} and Rose Plummer and Malone, {Daniel C}",
year = "2013",
month = "1",
doi = "10.1331/JAPhA.2013.12038",
language = "English (US)",
volume = "53",
pages = "39--45",
journal = "Journal of the American Pharmacists Association : JAPhA",
issn = "1544-3191",
publisher = "American Pharmacists Association",
number = "1",

}

TY - JOUR

T1 - Assessing patients' information needs regarding drug-drug interactions

AU - Mutebi, Alex

AU - Warholak, Terri L

AU - Hines, Lisa E.

AU - Plummer, Rose

AU - Malone, Daniel C

PY - 2013/1

Y1 - 2013/1

N2 - Objective: To assess patients' information needs regarding drug-drug interactions (DDIs) to inform patient DDI education resources. Design: Cross-sectional study. Setting: Online (United States in May 2011). Participants: Registered users of an online medication monitoring service (MediGuard). Intervention: Online questionnaire. Main outcome measure: Participants' information needs regarding DDIs and perceived importance of questions related to detecting and preventing harm from DDIs. Results: Characteristics of the 100 surveyed participants were as follows: 57% women, 88% white, 96% non-Hispanic, 71% retired, mean (±SD) age 65.2 ± 9.7 years (range 35-86). The number of prescription medications ranged from 2 to 22 (median 7) and the number of over-the-counter (OTC) medications from 1 to 10 (4). The most common concerns cited by participants were identification of interacting medications, seriousness of DDIs, interactions with OTC medications, interactions with foods, exacerbating comorbidities, short- and long-term adverse effects, signs and frequency of DDIs, and how to minimize adverse effects. Statistically significant differences based on gender, number of prescriptions, and number of OTC medications were observed in rankings of the importance of some DDI questions (P < 0.05). Conclusion: Patient-centered DDI education programs should consider addressing the seriousness of DDIs, the effect of DDIs on comorbidities, and interactions with OTC medications and foods and determining methods for identifying, minimizing, and managing DDIs.

AB - Objective: To assess patients' information needs regarding drug-drug interactions (DDIs) to inform patient DDI education resources. Design: Cross-sectional study. Setting: Online (United States in May 2011). Participants: Registered users of an online medication monitoring service (MediGuard). Intervention: Online questionnaire. Main outcome measure: Participants' information needs regarding DDIs and perceived importance of questions related to detecting and preventing harm from DDIs. Results: Characteristics of the 100 surveyed participants were as follows: 57% women, 88% white, 96% non-Hispanic, 71% retired, mean (±SD) age 65.2 ± 9.7 years (range 35-86). The number of prescription medications ranged from 2 to 22 (median 7) and the number of over-the-counter (OTC) medications from 1 to 10 (4). The most common concerns cited by participants were identification of interacting medications, seriousness of DDIs, interactions with OTC medications, interactions with foods, exacerbating comorbidities, short- and long-term adverse effects, signs and frequency of DDIs, and how to minimize adverse effects. Statistically significant differences based on gender, number of prescriptions, and number of OTC medications were observed in rankings of the importance of some DDI questions (P < 0.05). Conclusion: Patient-centered DDI education programs should consider addressing the seriousness of DDIs, the effect of DDIs on comorbidities, and interactions with OTC medications and foods and determining methods for identifying, minimizing, and managing DDIs.

KW - Drug information

KW - Drug interactions

KW - Patient preferences

UR - http://www.scopus.com/inward/record.url?scp=84890024702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890024702&partnerID=8YFLogxK

U2 - 10.1331/JAPhA.2013.12038

DO - 10.1331/JAPhA.2013.12038

M3 - Article

C2 - 23636154

AN - SCOPUS:84890024702

VL - 53

SP - 39

EP - 45

JO - Journal of the American Pharmacists Association : JAPhA

JF - Journal of the American Pharmacists Association : JAPhA

SN - 1544-3191

IS - 1

ER -